Enhanced susceptibility of CA3 hippocampus to prenatal nicotine exposure

J Dev Orig Health Dis. 2017 Apr;8(2):155-160. doi: 10.1017/S2040174416000775. Epub 2016 Dec 28.

Abstract

The brain is highly susceptible to adverse effects of drugs of abuse during early phases of life. Prenatal nicotine exposure (PNE), a preventable cause of gestational and infant mortality, can alter neuron wiring and induce sustained deficits in attention and learning. Here, a rat model of PNE (embryonic days 7-21) was used to examine the maturing hippocampus, which encodes new memories and processes emotional memory. Components of synaptic signaling were evaluated at postnatal day 14 (P14), a period of prolific synaptogenesis in rats, to determine if glutamatergic transmission-associated molecules are regulated in subregions of hippocampus as early as P14. PNE resulted in reduced expression of GluN2B, GluA2 and CaMKIIα, but elevated SNAP25 proteins specifically in the CA3 but not CA1. Only CaMKIIα was regulated in dentate gyrus at this age. These results suggest that glutamatergic and synaptic dysregulation of learning and memory may occur in hippocampus in a temporally and subregionally specific manner.

Keywords: animal; developmental stage; fetus/foetus; maternal pregnancy; outcome/system; small animals.

MeSH terms

  • Animals
  • CA3 Region, Hippocampal / drug effects*
  • CA3 Region, Hippocampal / pathology
  • Female
  • Nicotine / pharmacology*
  • Nicotinic Agonists / pharmacology*
  • Pregnancy
  • Prenatal Exposure Delayed Effects / chemically induced*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Nicotinic Agonists
  • Nicotine